Company news
Osteopore Ltd. (ASX:OSX) news
Osteopore Ltd. news releases on 6ix. Latest, Aug 5, 2026: OSX strikes orthopaedic deal for 5 Middle East countries
Press releases & updates
OSX strikes orthopaedic deal for 5 Middle East countries
August 5, 2026
Activities Report June 2026 and Appendix 4C
July 30, 2026
OSX secures Hainan FDA approval for orthopaedic devices
May 25, 2026
Activities Report March 2026 and Appendix 4C
April 29, 2026
Further Drawdown of T2 of the Redeemable Convertible Notes
March 26, 2026
Clarification - agreement for injectable regen bone filler
March 12, 2026
OSX signs agreement for injectable regenerative bone filler
March 11, 2026
OSX secures distribution for autologous dentin bone graft
March 2, 2026
Appendix 4E Preliminary Final Report
February 27, 2026
Drawdown of Tranche 2 of the Redeemable Convertible Notes
February 16, 2026
OSX secures Latin America deal for craniofacial distribution
February 12, 2026
Further Drawdown of T1 of the Redeemable Convertible Notes
February 6, 2026
Activities Report December 2025 and Appendix 4C
January 29, 2026
Clarification - agreement for orthopaedic products in HK
January 22, 2026
OSX strikes agreement for orthopaedic products in Hong Kong
January 21, 2026
Clarification - OSX partner Chinese dental & maxillofacial
January 16, 2026
OSX partners up for Chinese dental & maxillofacial market
January 15, 2026
OSX partners DKSH for dental products in Malaysia
November 24, 2025
Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants
November 13, 2025
Activities Report September 2025 and Appendix 4C
October 30, 2025
OSX collaborates with TTSH to develop novel implant for AVN
September 8, 2025
OSX Invests AUD 0.5m in Cellular Regenerative Medicine
August 31, 2025
Half Yearly Report and Accounts
August 29, 2025
OSX ortho product successful in Vietnam hospital tender bids
August 3, 2025
Activities Report June 2025 and Appendix 4C
July 30, 2025
Business progress update, Zimmer Biomet sales units grows 3x
July 28, 2025
Osteopore gains access to Switzerland
July 13, 2025
Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership
May 11, 2025
Activities Report March 2025 and Appendix 4C
April 28, 2025
Osteopore secures EU market approvals for custom implants
April 8, 2025
Reinstatement to Quotation
April 7, 2025
Suspension from Quotation
March 31, 2025
Convertible Note Prospectus
March 28, 2025
Drawdown of Tranche 1 of the Redeemable Convertible Notes
February 14, 2025
Activities Report December 2024 and Appendix 4C
January 30, 2025
OSX enters agreement to issue redeemable convertible notes
December 24, 2024
OSX partners scientists to drive regeneration innovation
November 3, 2024
Activities Report September 2024 and Appendix 4C
October 30, 2024
Osteopore to raise A$20m via redeemable convertible note
September 26, 2024
OSX and University of Chile complete bone implant studies
August 21, 2024
Activities Update Qtr Ending June 2024 and Appendix 4C
July 30, 2024
Osteopore strikes Exclusive Distribution with Zimmer Biomet
July 15, 2024
A$18.7m Osteopore, NDCS and A*STAR project hits milestones
June 5, 2024
OSX and SingHealth partner on Global Centre of Excellence
May 13, 2024
Osteopore successfully raises A$2.9m from Entitlement Offer
May 7, 2024
Activities Update Qtr Ending March 2024 and Appendix 4C
April 29, 2024
Response to ASX Price and Volume Query
April 23, 2024
Trading Halt
April 23, 2024
Pause in Trading
April 23, 2024
Reinstatement to Official Quotation
April 16, 2024